For example, the METTL3-AFF4-SOX2/MYC novel signaling axis was shown to promote self-renewal and tumor heterogeneity in bladder cancer stem cells (BCSCs), demonstrating the importance of m6A modifications [28]. The gene discussed is SOX2; the disease is urinary bladder carcinoma.